BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9000608)

  • 1. Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital.
    Swerdlow AJ; Barber JA; Horwich A; Cunningham D; Milan S; Omar RZ
    Br J Cancer; 1997; 75(1):116-23. PubMed ID: 9000608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hodgkin's lymphoma rectosigmoid in a patient with ulcerative colitis on long-term azathioprine therapy.
    Khuroo MS
    BMJ Case Rep; 2014 May; 2014():. PubMed ID: 24849639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stomach cancer risk after treatment for hodgkin lymphoma.
    Morton LM; Dores GM; Curtis RE; Lynch CF; Stovall M; Hall P; Gilbert ES; Hodgson DC; Storm HH; Johannesen TB; Smith SA; Weathers RE; Andersson M; Fossa SD; Hauptmann M; Holowaty EJ; Joensuu H; Kaijser M; Kleinerman RA; Langmark F; Pukkala E; Vaalavirta L; van den Belt-Dusebout AW; Fraumeni JF; Travis LB; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2013 Sep; 31(27):3369-77. PubMed ID: 23980092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of cancer for patients with rheumatoid arthritis versus general population: a national claims database cohort study.
    Beydon M; Pinto S; De Rycke Y; Fautrel B; Mariette X; Seror R; Tubach F
    Lancet Reg Health Eur; 2023 Dec; 35():100768. PubMed ID: 37954220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of individual malignant neoplasms in patients with sickle cell disease: English national record linkage study.
    Seminog OO; Ogunlaja OI; Yeates D; Goldacre MJ
    J R Soc Med; 2016 Aug; 109(8):303-9. PubMed ID: 27325377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer risks in recipients of renal transplants: a meta-analysis of cohort studies.
    Wang Y; Lan GB; Peng FH; Xie XB
    Oncotarget; 2018 Mar; 9(20):15375-15385. PubMed ID: 29632651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary malignancies across the age spectrum.
    Ng AK; Kenney LB; Gilbert ES; Travis LB
    Semin Radiat Oncol; 2010 Jan; 20(1):67-78. PubMed ID: 19959033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Review on Curability of Cancers: More Efforts for Novel Therapeutic Options Are Needed.
    Wang S; Liu Y; Feng Y; Zhang J; Swinnen J; Li Y; Ni Y
    Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31766180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological Profile of Ophir Loyola Cancer Hospital: A Snapshot of the Incidence of Solid Neoplasms in the Eastern Amazon.
    Chaves JR; Otake MIT; Alcantara DDFÁ; Lima RS; de Souza APB; da Costa Rodrigues JS; Imbiriba MMBG; Burbano RMR
    Med Sci (Basel); 2023 Oct; 11(4):. PubMed ID: 37987323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of second malignancies in patients with early-stage classical Hodgkin's lymphoma treated in a modern era.
    LeMieux MH; Solanki AA; Mahmood U; Chmura SJ; Koshy M
    Cancer Med; 2015 Apr; 4(4):513-8. PubMed ID: 25620577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of second lung cancer in Hodgkin's lymphoma survivors: a meta-analysis.
    Ibrahim EM; Kazkaz GA; Abouelkhair KM; Al-Mansour MM; Al-Fayea TM; Al-Foheidi M; Bayer AM; Elmasri OA
    Lung; 2013 Feb; 191(1):117-34. PubMed ID: 23053567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Declining use of radiotherapy in stage I and II Hodgkin's disease and its effect on survival and secondary malignancies.
    Koshy M; Rich SE; Mahmood U; Kwok Y
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):619-25. PubMed ID: 22251881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a population-based study.
    Royle JA; Baade PD; Joske D; Girschik J; Fritschi L
    Br J Cancer; 2011 Sep; 105(7):1076-81. PubMed ID: 21847118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From milk to malignancy: the role of mammary stem cells in development, pregnancy and breast cancer.
    Tiede B; Kang Y
    Cell Res; 2011 Feb; 21(2):245-57. PubMed ID: 21243011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of advanced melanoma upon withdrawal of immunosuppression: case series and literature review.
    Dillon P; Thomas N; Sharpless N; Collichio F
    Med Oncol; 2010 Dec; 27(4):1127-32. PubMed ID: 19890737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second primary malignancies after treatment for malignant lymphoma.
    Okines A; Thomson CS; Radstone CR; Horsman JM; Hancock BW
    Br J Cancer; 2005 Aug; 93(4):418-24. PubMed ID: 16106249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health care of young adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.
    Oeffinger KC; Mertens AC; Hudson MM; Gurney JG; Casillas J; Chen H; Whitton J; Yeazel M; Yasui Y; Robison LL
    Ann Fam Med; 2004; 2(1):61-70. PubMed ID: 15053285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: a search for common mechanisms.
    Dong C; Hemminki K
    Br J Cancer; 2001 Sep; 85(7):997-1005. PubMed ID: 11592772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Second malignancies after the therapy of Hodgkin's disease: the Freiburg collective 1940 to 1991].
    Slanina J; Heinemann F; Henne K; Moog G; Frommhold H
    Strahlenther Onkol; 1999 Apr; 175(4):154-61. PubMed ID: 10230457
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.